Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Letterkenny

4 clinical trials in Letterkenny, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Letterkenny at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Letterkenny

Open in trial search
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Nintedanib
  • Sponsor:Avalyn Pharma Inc.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Mediar Therapeutics Inc.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Cancer Trials Ireland

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Letterkenny

What the registry says about research in the country

01 Breast Cancer Research

Clinical investigations focusing on hormone receptor-positive and HER2-negative breast cancer patients with node-positive disease. These trials aim to optimize treatment strategies by evaluating the necessity of chemotherapy based on specific genomic indicators.

  • Personalized Treatment Approaches
  • Endocrine Therapy Optimization
  • Recurrence Risk Assessment

Research centers on determining the effectiveness of combining standard adjuvant endocrine therapy with chemotherapy, using genomic testing to guide treatment decisions.

02 Precision Oncology

Studies examining how genomic testing can inform treatment decisions for breast cancer patients. The research evaluates the relationship between recurrence scores and treatment outcomes to develop more precise therapeutic strategies.

  • Biomarker-Based Treatment
  • Treatment Response Prediction
  • Survival Outcome Analysis

This research aims to identify optimal treatment thresholds and improve disease-free survival through personalized medicine approaches.

03 Treatment Optimization

Clinical research exploring the selective use of chemotherapy in breast cancer treatment protocols. The studies focus on identifying patients who can safely avoid chemotherapy while maintaining optimal treatment outcomes.

  • Treatment De-escalation
  • Quality of Life Impact
  • Risk-Adapted Therapy

These trials aim to refine treatment algorithms and reduce unnecessary therapy while maintaining therapeutic efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.